# A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.

> **NCT06587035** · — · RECRUITING · sponsor: **Pfizer** · enrollment: 50 (estimated)

## Conditions studied

- Dwarfism, Pituitary

## Interventions

- **DRUG:** Somatrogon

## Key facts

- **NCT ID:** NCT06587035
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-30
- **Primary completion:** 2026-09-21
- **Final completion:** 2028-09-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06587035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06587035, "A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06587035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*